Symbios Orthopédie SA
Tom Troup is currently the General Manager for Symbios Orthopédie SA in the USA. Prior to this role, Tom held leadership positions at Agility Performance Group, LLC, Epix Orthopaedics, Inc., and Smith & Nephew. With a strong background in marketing and commercialization within the MedTech sector, Tom has a proven track record of driving revenue growth and developing effective marketing strategies. Tom holds an MBA in Finance from Indiana University and a BS in Finance and Mathematics from Ball State University.
This person is not in any teams
This person is not in any offices
Symbios Orthopédie SA
Symbios is a Swiss medical technology company, and the leader in custom-made orthopaedic implants for hip and knee joint replacement. It was founded in 1989 by Jean Plé and two associates, including an orthopedic surgeon. Their vision was to design and manufacture custom-made implants that adapt perfectly to each patient’s individual anatomy. As there are as many different body shapes as there are patients, a custom-made implant is above all a unique implant for a unique patient, designed to better restore mobility and satisfaction. Since its creation and based today on 30 years of experience, Symbios has pioneered and constantly improved the technology of custom implant manufacturing, thus becoming the company with the greatest expertise in this field worldwide. In addition to providing products that are better adapted to patients, customization of implants enables a major breakthrough in today’s orthopedic supply model, allowing for a significant reduction in stocks and instruments for healthcare facilities. The cost of healthcare linked to changing demographics is a growing concern, and we believe that this is the ultimate way to maximize the efficiency of healthcare facilitiesand enable them to reduce operational costs in the future, while improving the quality of care.